MedPath

Poliovirus type 1 antigen (formaldehyde inactivated)

Generic Name
Poliovirus type 1 antigen (formaldehyde inactivated)
Brand Names
Ipol, Kinrix, Pediarix, Pentacel, Quadracel, Vaxelis
Drug Type
Biotech
Unique Ingredient Identifier
0LVY784C09

Overview

Poliovirus type 1 antigen is a suspension of poliovirus Type 1 (Mahoney) used in the active immunization of infants (as young as 6 weeks of age), children, and adults for the prevention of poliomyelitis caused by poliovirus Type 1. The vaccine contains purified and inactivated poliovirus type 1 that were grown from a continuous line of monkey kidney cells.

Indication

No indication information available.

Associated Conditions

  • Poliomyelitis caused by Poliovirus
  • Poliomyelitis caused by poliovirus type 1

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
GlaxoSmithKline Biologicals SA
58160-812
INTRAMUSCULAR
40 [iU] in 0.5 mL
11/26/2024

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
INFANRIX HEXA VACCINE
SIN12288P
INJECTION
40 du/0.5 ml
5/7/2003
Tetraxim Vaccine
SIN15026P
INJECTION, SUSPENSION
40 DU/0.5ml
6/6/2016

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
INFANRIX-IPV
02241284
Suspension - Intramuscular
40 UNIT / 0.5 ML
10/25/2012
PEDIACEL
02243167
Suspension - Intramuscular
29 UNIT / 0.5 ML
10/4/2007
BOOSTRIX-POLIO
02312557
Suspension - Intramuscular
40 D / 0.5 ML
10/22/2010
INFANRIX-IPV/HIB
02257122
Suspension - Intramuscular
40 UNIT / 0.5 ML
10/25/2012

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.